Perspectives and Preferences of People with Type 2 Diabetes for the Attributes of Weekly Insulin
PwT2D valued insulin efficacy and reducing treatment-related adverse events, with heterogeneity in the relative importance of administration frequency. All else being equal, respondents preferred weekly over daily basal insulin. These findings provide insights into the preferences of PwT2D considering weekly long-acting insulin.
Authors
- Katherine Kosa (ORCID: https://orcid.org/0000-0002-6461-527X)
- Magaly Perez‐Nieves (ORCID: https://orcid.org/0000-0002-6264-1095)
- FELICIA GELSEY (ORCID: https://orcid.org/0000-0002-2038-4094)
- Jiat Ling Poon (ORCID: https://orcid.org/0000-0001-7038-2102)
- Dana Britt DiBenedetti (ORCID: https://orcid.org/0000-0003-2294-9519)
- Caroline Vass (ORCID: https://orcid.org/0000-0002-6385-2812)
- Anna Pierce (ORCID: https://orcid.org/0000-0002-3918-0091)
- Carol Mansfield (ORCID: https://orcid.org/0000-0002-3144-8938)
- David Schapiro (ORCID: https://orcid.org/0000-0002-3083-3615)
Institutions
- Eli Lilly (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1007/s13300-024-01652-0
- Citations
- 7
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.50
Funders
- Eli Lilly and Company